Compile Data Set for Download or QSAR
Found 606 with Last Name = 'block' and Initial = 'mh'
TargetKinesin-like protein KIF11(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50353767(CHEMBL1829430)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant C-terminal His6-tagged KSP ATPase activity after 1 hr by malachite green assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZC838ZPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50116590(CHEMBL325486 | N-(9-Methanesulfonyl-9H-carbazol-3-...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7N3KPubMed
TargetKinesin-like protein KIF11(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50353767(CHEMBL1829430)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant C-terminal His6-tagged KSP ATPase activity after 1 hr by malachite green assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZC838ZPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50116610(CHEMBL119743 | N-(9-Isopropyl-9H-carbazol-3-yl)-3-...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7N3KPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50343726((S)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)ethylamino...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of human JAK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PN95ZDPubMed
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50392791(CHEMBL2151321 | US8486966, 1)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:Inhibition of AblMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9K2GPubMed
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50392791(CHEMBL2151321 | US8486966, 1)copy SMILEScopy InChI
Affinity DataIC50: 1.40nMAssay Description:Inhibition of TrkAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9K2GPubMed
TargetKinesin-like protein KIF11(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50353788(CHEMBL1829433)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant C-terminal His6-tagged KSP ATPase activity after 1 hr by malachite green assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZC838ZPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50116602(CHEMBL419951 | Morpholine-4-carboxylic acid (9-iso...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7N3KPubMed
TargetKinesin-like protein KIF11(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50353788(CHEMBL1829433)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of human recombinant C-terminal His6-tagged KSP ATPase activity after 1 hr by malachite green assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZC838ZPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50116619(CHEMBL117563 | Morpholine-4-carboxylic acid (9-iso...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7N3KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50116600(CHEMBL325475 | N-(9-Ethyl-9H-carbazol-3-yl)-3-pyri...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7N3KPubMed
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50392791(CHEMBL2151321 | US8486966, 1)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:Inhibition of Flt3More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9K2GPubMed
TargetTyrosine-protein kinase Fgr(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50392791(CHEMBL2151321 | US8486966, 1)copy SMILEScopy InChI
Affinity DataIC50: 2.20nMAssay Description:Inhibition of FgrMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9K2GPubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50388781(CHEMBL2062585)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of recombinant human full length N-terminal His6-tagged CK2alpha expressed in Sf21 insect cells using CK2tide as substrate treated for 20 ...More data for this Ligand-Target Pair
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50343726((S)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)ethylamino...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of human TRKAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PN95ZDPubMed
TargetHomeodomain-interacting protein kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50460939(CHEMBL4228654)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of HIPK2 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB84H6PubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of recombinant human full length N-terminal His6-tagged CK2alpha expressed in Sf21 insect cells using CK2tide as substrate treated for 20 ...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50460939(CHEMBL4228654)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of PIM3 (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB84H6PubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50437434(CHEMBL2409175)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of recombinant human full length N-terminal His6-tagged CK2alpha expressed in Sf21 insect cells using CK2tide as substrate treated for 20 ...More data for this Ligand-Target Pair
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50460945(CHEMBL4225287)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of recombinant human full length N-terminal His6-tagged CK2alpha expressed in Sf21 insect cells using CK2tide as substrate treated for 20 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DB84H6PubMed
TargetKinesin-like protein KIF11(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50353767(CHEMBL1829430)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of human recombinant C-terminal His6-tagged KSP ATPase activity after 1 hr by malachite green assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZC838ZPubMed
TargetKinesin-like protein KIF11(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50353799(CHEMBL1829424)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of human recombinant C-terminal His6-tagged KSP ATPase activity after 1 hr by malachite green assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZC838ZPubMed
TargetKinesin-like protein KIF11(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50353799(CHEMBL1829424)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of human recombinant C-terminal His6-tagged KSP ATPase activity after 1 hr by malachite green assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2ZC838ZPubMed
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50335201(5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TrkAMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M32WRMPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50335202(5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 using Km ATP concentrationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M32WRMPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50335203(CHEMBL1650698 | N4-(5-Cyclopropyl-1H-pyrazol-3-yl)...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 using Km ATP concentrationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M32WRMPubMed
TargetBaculoviral IAP repeat-containing protein 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50001129(CHEMBL3236390)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZJ7PubMed
TargetBaculoviral IAP repeat-containing protein 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50001129(CHEMBL3236390)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZJ7PubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50343727((S)-5-chloro-2-(1-(5-fluoropyridin-2-yl)ethylamino...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 after 60 minMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PN95ZDPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50343726((S)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)ethylamino...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 after 60 minMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PN95ZDPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50343725((S)-5-fluoro-2-(1-(4-fluorophenyl)ethylamino)-6-(5...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 after 60 minMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PN95ZDPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50116592(CHEMBL325226 | Morpholine-4-carboxylic acid (9-iso...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7N3KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50116605(CHEMBL432628 | Morpholine-4-carboxylic acid (6-flu...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7N3KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50116617(CHEMBL116210 | N-(9-Acetyl-9H-carbazol-3-yl)-3-pyr...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Binding affinity to the human Neuropeptide Y receptor Y5 (NPY5)More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q27S7N3KPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50343723((S)-6-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-fluor...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of JAK2 after 60 minMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2PN95ZDPubMed
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50392791(CHEMBL2151321 | US8486966, 1)copy SMILEScopy InChI
Affinity DataIC50: 3.5nMAssay Description:Inhibition of BTKMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GH9K2GPubMed
TargetSerine/threonine-protein kinase pim-3(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50387299(CHEMBL2048873)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of human PIM3 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATPMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2348MDSPubMed
TargetSerine/threonine-protein kinase pim-1(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50387299(CHEMBL2048873)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of human PIM1 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 5 mM ATPMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2348MDSPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50335212(CHEMBL1650725 | N2-[(1S)-1-(5-fluoropyrimidin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of JAK2 using 5 mM of ATPMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M32WRMPubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50335205(5-bromo-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of JAK2 using Km ATP concentrationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M32WRMPubMed
TargetE3 ubiquitin-protein ligase XIAP(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50001129(CHEMBL3236390)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of XIAP BIR3 domain (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZJ7PubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50335210(5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of JAK2 using Km ATP concentrationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M32WRMPubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50388788(CHEMBL2062566)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of full length N-terminus His-tagged human CK2alpha expressed in insect Sf21 cells using BODIPY-FL-RRRDDDSDDD-CONH2 as substrate after 20 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N24GSPubMed
TargetCasein kinase II subunit alpha(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50388805(CHEMBL2062571)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of full length N-terminus His-tagged human CK2alpha expressed in insect Sf21 cells using BODIPY-FL-RRRDDDSDDD-CONH2 as substrate after 20 ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N24GSPubMed
TargetE3 ubiquitin-protein ligase XIAP(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50001129(CHEMBL3236390)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of XIAP BIR3 domain (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2416ZJ7PubMed
TargetTyrosine-protein kinase JAK2(Homo sapiens (Human))
AstraZeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50335209(5-fluoro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of JAK2 using Km ATP concentrationMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2M32WRMPubMed
TargetSerine/threonine-protein kinase pim-2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50387308(CHEMBL2048866)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATPMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2348MDSPubMed
TargetSerine/threonine-protein kinase pim-2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50387295(CHEMBL2048868)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATPMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2348MDSPubMed
TargetSerine/threonine-protein kinase pim-2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50387298(CHEMBL2048872)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of human PIM2 using FITC-(AHX)RSRHSSYPAGT-COOH as substrate after 90 mins by mobility shift assay in presence of 50 uM ATPMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2348MDSPubMed
Displayed 1 to 50 (of 606 total ) | Next | Last >>
Jump to: